As observed, the ERK1/2 (Extracellular Signal Regulated Kinase 1/2), which mitogens can activate, has been established as a significant oncogenic signaling pathway in cancer cells, including HNSCC development [39, 40]. The gene discussed is MAPK3; the disease is cancer.